Co to jest strona internetowa?

https://journals.viamedica.pl/clinical_diabetology, https://www.researchgate.net/journal/Clinical-Diabetology-2450-8187

Clinical Diabetology, Ulica Świętokrzyska 73, Gdansk (2026)

06/11/2025

🎉 Clinical Diabetology — New issue Vol. 14, No. 5 (2025) is online!

Dear Readers,
We’re delighted to announce the publication of the latest issue of Clinical Diabetology. This edition spans translational insights on the gut microbiome in T2D remission, cross-sectional and prevalence studies from diverse populations, and practical guidance around mental health screening in diabetes care.

🔹 Editorial
• Microbial Signatures of Type 2 Diabetes Remission — Toward a New Therapeutic Frontier — an expert perspective linking remission durability with microbiome re-equilibration and barrier integrity, and mapping opportunities for microbiome-targeted interventions.

🔹 Research papers
• Fasting Serum Adiponectin Shows No Association with Body Mass Index in Pregnant Women with or without Gestational Diabetes — cross-sectional data (n=81) at 24–28 weeks: adiponectin comparable in GDM vs. NGT and not correlated with BMI or glycemia.
• Prevalence and Determinants of Metabolic Syndrome in Young Adults — Insights from a Jordanian Medical Student Cohort — MetS prevalence 7.6% (IDF criteria); BMI is the strongest correlate; lifestyle signals (diet, activity) emerge as modifiable levers.
• Prevalence of Cardiac Autonomic Neuropathy (CAN) in Patients with Type 2 Diabetes Mellitus — the Interest of Studying Cardiovascular Autonomic Tests — a prevalence-focused report emphasizing standardized autonomic testing.
• Ramadan Fasting in Young Adults with Type 1 Diabetes — Influence of Insulin Type and Glycemic Control — pragmatic observations around fasting, insulin regimen choice and control.

🔹 Review articles
• Psychometric Properties of the Polish Versions of Mental Health Screening Tools for Patients with Diabetes: the WHO-Five Well-Being Index (WHO-5), Patient Health Questionnaire-9 (PHQ-9), and Problem Areas in Diabetes (PAID) — a Review — practical psychometrics for routine mental-health screening in diabetes clinics.
• Comparison of Gut Microbiota Composition in Type 2 Diabetes Remission and Non-Remission (COMMUTER Study) — A Systematic Review — cross-study profiling of taxa linked with remission vs. non-remission states.

Full issue online: https://journals.viamedica.pl/clinical_diabetology/issue/view/6714

22/10/2025

How does GDM remodel the term placenta?
Early-online research (n=100 GDM vs 100 controls) pairs Van Gieson histochemistry with IHC (CD117 for telocytes, CD68 for Hofbauer cells) and precise ocular micrometry (400×). Key signals: larger villi, greater stromal collagen, altered telocyte phenotype with reduced CD117 intensity, and higher Hofbauer cell burden/stronger CD68 signal—altogether pointing to stromal fibrosis + immune rewiring that may impact fetoplacental exchange. Methods and statistics are clearly laid out (unpaired t-tests; standardized intensity scoring).

Authors: Vengadesan B., Balaji Karunakaran, K.V.P. Suriyakumari.
📖 Online first: https://journals.viamedica.pl/clinical_diabetology/article/view/108118

02/09/2025

🧪 Clinical Diabetology — New Issue Alert!
Vol. 14, No. 4 (2025) is now online. This issue explores adiposity metrics and glycemic risk, medication adherence in older adults, AI in exams, prediabetic neuropathy, diabetes–colorectal polyp links, and MASLD–T2D therapeutics. A valuable collection for clinicians and researchers alike.

Dear Readers, for your reading pleasure, the Table of Contents includes:

RESEARCH PAPERS
📌 Bioimpedance Visceral Adiposity Parameters Are Associated With Glycemic Dysregulation (LUCAS 1.2) — Cross-sectional Real-world Data Analysis
📌 Medication Adherence and its Associated Factors and Glycemic Control in Older Outpatients with Type 2 Diabetes Mellitus in Vietnam
📌 ChatGPT-3.5 and ChatGPT-4o Performance in the Specialty Certificate Examination in Diabetology: A Comparative Study
📌 The Prevalence of Peripheral Neuropathy in a Cohort of Egyptians with Prediabetes. Clinical and Electrophysiological Study
📌 Association Between Type 2 Diabetes and Colorectal Polyps: A Cross-Sectional Study

LETTER TO THE EDITOR
📌 Investigation of Factors Influencing Blood Glucose Improvement with Tirzepatide

REVIEW ARTICLE
📌 Impact of Various Oral Hypoglycemic Agents on Hepatic Steatosis Reduction in MASLD and Type 2 Diabetes: Exploring the Bidirectional Relationship. A Narrative Review

OBSERVATION LETTER
📌 “Gum Disease and Diabetes: Journey from Consensus to Clinical Practice” — Proceedings from the Diabetes India Oral Health Group (DIOH) Symposium Cum Workshop, 2024, New Delhi, India

📖 Read the full issue here: https://journals.viamedica.pl/clinical_diabetology/issue/view/6677

Stay current and share with your network 🙌

10/07/2025

📢 New issue of Clinical Diabetology (Vol. 14, No. 3 / 2025) is now available online!

Dear Readers,

We are pleased to inform you that the latest issue of Clinical Diabetology has just been published. This edition brings together expert commentaries, original research, and systematic reviews on the challenges and advancements in the care of patients with diabetes — including novel therapeutics, digital monitoring, and real-world clinical data. 🧬📊

🔍 Highlights from the table of contents:

🔷 Editorials
🔹 Tirzepatide: Responders vs. Non-Responders
🔹 Imeglimin in Metformin-Intolerant Patients with Type 2 Diabetes: A Clinical Advancement for Real-World Challenges

🔷 Original Articles
🔹 Maternal and Fetal Implications of Gestational Diabetes Mellitus: A Retrospective, Longitudinal Study
🔹 Safety and Efficacy of Imeglimin in Type 2 Diabetes Individuals with Metformin Intolerance: A Case-Control Study
🔹 Assessment of Diabetes Distress and Its Association with Medication Adherence Among Type 2 Diabetes Patients: A Prospective Cross-Sectional Study
🔹 Association Between Glycation Gap and Renal Complications in People with Type 2 Diabetes
🔹 Intermittently Scanned Continuous Glucose Monitoring in Patients with Type 2 Diabetes in the United Arab Emirates: A Retrospective Analysis

🔷 Review Article
🔹 Efficacy and Safety of Bexagliflozin, a Selective Sodium-Glucose Cotransporter-2 Inhibitor, in Type 2 Diabetes: A Systematic Review and Meta-Analysis

🔷 Letters
🔹 Tirzepatide-Induced Weight Loss and Free Triiodothyronine Exhibit a Negative Correlation
🔹 Effect of Tirzepatide on Blood Pressure in Patients with High Salt Intake

📖 Read the full issue here:
👉 https://journals.viamedica.pl/clinical_diabetology

✍️ Submission Guidelines for Authors:
https://journals.viamedica.pl/clinical_diabetology/about/submissions

📬 For inquiries: joanna.tykarska@viamedica.pl

06/05/2025

New issue of Clinical Diabetology Vol. 14 No. 2 (2025) is now available online.

The latest edition presents a wide range of clinical studies, expert recommendations, and case-based insights into type 2 diabetes management.

The issue opens with an editorial:

The Emerging Trend of Managing Type 2 Diabetes with Oral Semaglutide
— Supratik Bhattacharyya
It explores the growing role of oral semaglutide as a convenient and effective option in diabetes care, especially in India.

Key original articles include:
♦ Medication Adherence and Quality of Life Among Type 2 Diabetes Patients: A Cross-Sectional, Observational Study in Eastern India
♦ Effect of Short-Term Basal Insulin Initiation in Newly Diagnosed Type 2 Diabetes on One-Year Glycemic Control: Prospective Cohort, Interventional, Two-Arm Study
♦ A Randomized Controlled Trial of Aloe Vera Versus Thyme Honey Oral Rinse in the Management of Xerostomia in Type 2 Diabetes
♦ Frailty, Medication Adherence, and Glycemic Control in Patients with Type 2 Diabetes: A Cross-Sectional Study Among Metformin- and Non-Metformin-Exposed Groups

Guidelines:
♦ Expert Opinion on Cardio-Renal-Metabolic Approach to Management of Adults with Type 2 Diabetes Mellitus Using Oral Semaglutide: An Indian Perspective

Review articles:
♦ Premeal Load of Macronutrients as an Effective Nutritional Strategy to Control Postprandial Glycemia

Additionally:
♦ Letters, such as Hemifacial Spasm Associated with Severe Hyperglycemia in a Patient with New-Onset Type 2 Diabetes: A Case Report and Review of the Literature

Explore the full issue here:
https://journals.viamedica.pl/clinical_diabetology

24/02/2025

🔬 We’re Now on ResearchGate! 🔬

Great news! Clinical Diabetology is now available on ResearchGate! 🎉

📚 What does this mean for you?
✔️ Easy access to the latest research in diabetes care and management
✔️ Stay updated with groundbreaking studies in diabetology
✔️ Connect & collaborate with experts and researchers worldwide
✔️ Engage in discussions on the latest advancements in diabetes treatment

📌 Check out our profile and follow us:
🔗 https://www.researchgate.net/journal/Clinical-Diabetology-2450-8187

19/12/2024

Reality of Real-World Experience with Oral Semaglutide in Type 2 Diabetes
Oral semaglutide, the first oral GLP-1 receptor agonist (GLP-1 RA), has demonstrated significant efficacy in managing type 2 diabetes (T2D). Approved by the US FDA in 2019, it offers notable advantages in reducing glycated hemoglobin (HbA1c) and body weight.

Key Real-World Findings
🔷 HbA1c Reduction: Global studies report reductions of up to –1.9% at 18 months, with a mean decrease of ~–1.0%. Greater reductions were observed in patients with higher baseline HbA1c.
🔷 Weight Loss: Consistent weight loss of –2.8 kg to –6.0 kg was achieved, with Indian cohorts showing reductions up to –5.3 kg.
🔷 Dose Tolerability: Many patients were maintained on 7 mg doses due to tolerability issues, though maximal benefits were evident at 14 mg.

Clinical Implications
Oral semaglutide provides an effective alternative to injectable GLP-1 RAs, improving adherence due to its oral formulation. Future studies should address its long-term impact on cardiovascular and renal outcomes.

Authors
Awadhesh Kumar Singh, Akriti Singh, Ritu Singh, Jayshree Swain

For detailed findings, access the full publication:
https://journals.viamedica.pl/clinical_diabetology/article/view/103963

30/10/2024

📢 The latest issue of Clinical Diabetology is now available online!

Dear Readers,

We are pleased to announce the publication of the newest issue of Clinical Diabetology, Vol. 13, No. 5 (2024).
In this issue, you’ll find a range of articles addressing essential and timely topics in type 2 diabetes, its complications, and innovative approaches to treatment and diagnosis.

Highlights include:
✅ Research on the coexistence of cortisol excess and type 2 diabetes,
✅ Analysis of pancreatic and hepatic steatosis in women with type 2 diabetes,
✅ Comparative studies on the effectiveness of antidiabetic medications in real-world clinical settings.

Additionally, this issue features literature reviews exploring novel therapeutic approaches and biological mechanisms related to diabetes. 📖

We invite you to explore the full issue here:
👉 https://journals.viamedica.pl/clinical_diabetology/issue/archive?issueId=6410

28/10/2024

Cut-Off Point Value to Evaluate Abnormality of Systolic Deformation Parameters in Patients with Type 2 Diabetes.

Heart failure is a significant risk for people with type 2 diabetes (T2D). This study, published in Clinical Diabetology, evaluates specific cut-off values for systolic deformation parameters, providing new insights into early detection of left ventricular dysfunction in T2D patients. Speckle tracking echocardiography (STE) reveals subclinical heart abnormalities even with normal ejection fraction, helping to better assess cardiac health. 💓

Key findings:
✅ Abnormal global longitudinal strain (GLS) observed in 78.6% of T2D patients (cut-off: -19%)
✅ Significant prevalence of abnormal GLSR (65.1%) and GCSR (60.9%)
✅ STE provides greater sensitivity in detecting early cardiac dysfunction

Read more: https://journals.viamedica.pl/clinical_diabetology/article/view/100784

Authors: Nguyen Trang Nguyen, Anh Vu Nguyen, Van Chi Le, Hoang Thuy Linh Nguyen, Hoa Thi Phu, Anh Tien Hoang

27/09/2024

🌟 The Interplay between Gut Dysbiosis and Diabetic Nephropathy: Implications for Treatment and Management 🌟

🔬 A new study highlights the significant role of the gut microbiome in the pathogenesis of diabetic nephropathy. Gut dysbiosis exacerbates renal dysfunction via increased systemic inflammation and endothelial damage, accelerating disease progression. The authors explore the therapeutic potential of microbiome-targeted interventions in managing diabetic nephropathy.

👉 Read the full article here:
https://journals.viamedica.pl/clinical_diabetology/article/view/102332

Authors: Jay Mehta, Michał Czech, Włodzimierz Bułhak, Marek Kos.

01/08/2024

Adverse Drug Reactions and Prescribing Patterns of Antidiabetic Medications in Type 2 Diabetes Patients: An Observational Ambispective Study 🌟
🔬 Did you know that managing Type 2 Diabetes (T2D) involves a complex interplay of medications that can sometimes lead to adverse drug reactions (ADRs)?

📊 A recent six-month study conducted on 615 T2D patients revealed critical findings about the prescribing patterns and ADRs associated with antidiabetic medications.

💡 Key Highlights:

✅ Prevalence of ADRs: 35.8% of patients experienced at least one ADR.
✅ Gender Differences: Higher occurrence among females (37.6%) compared to males (34.4%).
✅ Commonly Prescribed Medications: Biguanides, followed by DPP-4 inhibitors and thiazolidinediones.
✅ Frequent ADRs: Gastrointestinal disturbances, weakness, and tiredness were the most reported.
👩‍⚕️ The study underscores the importance of vigilant monitoring and the need for optimal treatment strategies to manage ADRs effectively.

👉 Dive deeper into these findings and explore how they can impact clinical practices in the latest issue of "Clinical Diabetology" Vol 13, No 3 (2024).
Read the full article here:
https://journals.viamedica.pl/clinical_diabetology/article/view/100105

03/07/2024

🌟 New Discoveries in Type 2 Diabetes Treatment! 🌟

🔬 Did you know that handgrip strength might be linked to LDL cholesterol levels in patients with type 2 diabetes? The latest research published in Clinical Diabetology, Vol 13, No 3 (2024), brings intriguing findings!

📊 In a study conducted on 68 patients with , it was found that higher relative handgrip strength (RHGS) positively correlates with LDL cholesterol levels (r = 0.349). What does this mean for patients? It suggests that LDL-C levels might affect muscle strength and quality.

🔎 Although the results did not show a correlation between RHGS and levels of triglycerides (TG) or high-density lipoprotein cholesterol (HDL-C), they indicate the need for further research in this area. Surprising? It’s possible that LDL-C is a new factor influencing muscle strength in T2D patients.

💡 These findings could have significant implications for the secondary prevention of cardiovascular diseases in type 2 diabetes patients. Monitoring RHGS could help detect early signs of sarcopenia, especially when using cholesterol-lowering medications.

👉 Want to learn more about these fascinating discoveries? Read the full article in the latest issue of Clinical Diabetology!

📘 https://journals.viamedica.pl/clinical_diabetology/article/view/99322

Clinical Diabetology

06/11/2025

22/10/2025

02/09/2025

10/07/2025

06/05/2025

24/02/2025

19/12/2024

30/10/2024

28/10/2024

27/09/2024

01/08/2024

03/07/2024

Adres

Strona Internetowa

Ostrzeżenia

Skróty

Udostępnij

Kategoria